U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
RIMTERAVIMAB
INN  
Official Name English
IMMUNOGLOBULIN GAMMA1 VH-H-CH2-CH3 DIMER, ANTI-(RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE (S)GLYCOPROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROMECORONAVIRUS (SARS-COV) / SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2 (SARS-COV-2) / BAT SARSLIKE(BAT) CORONA
Preferred Name English
rimteravimab [INN]
Common Name English
XVR 011 [WHO-DD]
Common Name English
Code System Code Type Description
CAS
2540797-21-3
Created by admin on Wed Apr 02 11:15:22 GMT 2025 , Edited by admin on Wed Apr 02 11:15:22 GMT 2025
PRIMARY
FDA UNII
Z4LZB5VCU4
Created by admin on Wed Apr 02 11:15:22 GMT 2025 , Edited by admin on Wed Apr 02 11:15:22 GMT 2025
PRIMARY
NCI_THESAURUS
C183318
Created by admin on Wed Apr 02 11:15:22 GMT 2025 , Edited by admin on Wed Apr 02 11:15:22 GMT 2025
PRIMARY
SMS_ID
300000029231
Created by admin on Wed Apr 02 11:15:22 GMT 2025 , Edited by admin on Wed Apr 02 11:15:22 GMT 2025
PRIMARY
INN
12047
Created by admin on Wed Apr 02 11:15:22 GMT 2025 , Edited by admin on Wed Apr 02 11:15:22 GMT 2025
PRIMARY
ACTIVE MOIETY
RIMTERAVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966